12:00 AM
Jan 04, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Emmelle dextrin sulphate: Began Phase II testing

ML Laboratories plc (LSE:MLB), Liverpool, U.K.
Product: Emmelle dextrin sulphate
Business: Infectious diseases
Therapeutic category: Viral infection
Target: Epithelial cells...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >